Vaccine For Omicron
- All
- News
- Videos
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
What You Need to Know About Moderna's New Vaccine For Omicron
Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
US Medical Experts Call For Omicron-Specific Covid Boosters
A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Amazon Terminates Paid COVID-19 Paid Leave Policy for Workers in the US
Amazon has updated its policy following the availability of COVID-19 vaccines and revised guidance from the US’ Centers for Disease Control and Prevention.
-
Omicron Lasts 3 Days Less Than Delta For Boosted: Study
People who are vaccinated and have had a booster shot against Covid-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.
-
Fourth Covid Shot Provides Little Benefit Against Omicron: Study
A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.
-
Australia Approves Covid Vaccine Boosters For 16- And 17-Year-Olds
Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.
-
Omicron Dominant Variant, Early Indication Of Plateau In Cases: Centre
The government credited wide vaccination coverage for a fall in the number of deaths. "Active case numbers and corresponding deaths are much lower in this wave," it said and pointed out that the severity of infections is also relatively lower.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
What You Need to Know About Moderna's New Vaccine For Omicron
Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
US Medical Experts Call For Omicron-Specific Covid Boosters
A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Amazon Terminates Paid COVID-19 Paid Leave Policy for Workers in the US
Amazon has updated its policy following the availability of COVID-19 vaccines and revised guidance from the US’ Centers for Disease Control and Prevention.
-
Omicron Lasts 3 Days Less Than Delta For Boosted: Study
People who are vaccinated and have had a booster shot against Covid-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.
-
Fourth Covid Shot Provides Little Benefit Against Omicron: Study
A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.
-
Australia Approves Covid Vaccine Boosters For 16- And 17-Year-Olds
Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.
-
Omicron Dominant Variant, Early Indication Of Plateau In Cases: Centre
The government credited wide vaccination coverage for a fall in the number of deaths. "Active case numbers and corresponding deaths are much lower in this wave," it said and pointed out that the severity of infections is also relatively lower.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
